Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Fredun Pharmaceuticals Financial Results

Fredun Pharmaceuticals approved FY2026 audited financial results and recommended a 7% final dividend. The board also proposed a 2:1 bonus share issue and increased authorized capital.

Source

BSE filing, NSE: FREDUN. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Fredun Pharmaceuticals Ltd: key numbers

Share price
₹1,471.70
Market cap
₹2,109 Cr
Revenue (annual)
₹635.5 Cr
Net profit (annual)
₹32.62 Cr
P/E (TTM)
48.1×Sector 46.1×
Promoter holding
43.62%-0.95% QoQ
FII holding
0.69%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Fredun Pharmaceuticals Ltd

All →
18:26 IST BSE
Convertible Warrants

Fredun Pharmaceuticals Convertible Warrants

Fredun Pharmaceuticals allotted 44,000 equity shares to three non-promoter investors on conversion of 14,667 warrants. The conversion follows the 1:2 bonus issue, which adjusted warrant entitlements.

Other financial results announcements

All →